BFG
ABBV icon

Bleakley Financial Group’s AbbVie ABBV Stock Holding History

Bleakley Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.2M Buy
92,109
+19,566
+27% +$4.21M 0.3% 66
2026
Q1 		$15.8M Sell
72,543
-2,871
-4% -$637K 0.25% 72
2025
Q4 		$17.2M Buy
75,414
+5,367
+8% +$1.22M 0.3% 59
2025
Q3 		$16.2M Buy
70,047
+2,897
+4% +$590K 0.38% 48
2025
Q2 		$12.5M Buy
67,150
+534
+0.8% +$99.2K 0.32% 60
2025
Q1 		$14M Buy
66,616
+6,934
+12% +$1.35M 0.45% 43
2024
Q4 		$10.6M Buy
59,682
+9,879
+20% +$1.82M 0.32% 54
2024
Q3 		$9.84M Sell
49,803
-70,514
-59% -$13.2M 0.3% 53
2024
Q2 		$20.6M Buy
120,317
+2,776
+2% +$460K 0.6% 27
2024
Q1 		$21.4M Buy
117,541
+6,158
+6% +$1.06M 0.62% 25
2023
Q4 		$17.3M Sell
111,383
-549
-0.5% -$80K 0.55% 33
2023
Q3 		$16.7M Buy
111,932
+11,355
+11% +$1.67M 0.59% 33
2023
Q2 		$13.6M Buy
100,577
+13,167
+15% +$1.93M 0.42% 46
2023
Q1 		$13.9M Sell
87,410
-25,945
-23% -$3.97M 0.47% 38
2022
Q4 		$18.3M Buy
+113,355
New +$17.4M 0.66% 27

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bleakley Financial Group's ABBV Position: Q2 2026 in Review

Bleakley Financial Group increased its AbbVie (ABBV) stake by 27% in Q2 2026, buying an estimated $4.21M and bringing the position to 92,109 shares worth $23.2M. The position accounts for 0.3% of the portfolio, ranked #66.

Bleakley Financial Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bleakley Financial Group held 92,109 shares of AbbVie worth $23.2M as of Q2 2026.
  • Bleakley Financial Group bought 19,566 AbbVie shares in Q2 2026, an estimated $4.21M.
  • AbbVie made up 0.3% of Bleakley Financial Group's portfolio in Q2 2026, its #66 holding.
  • Bleakley Financial Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.